Gut Microbe–Mediated Suppression of Inflammation-Associated Colon Carcinogenesis by Luminal Histamine Production

Chunxu Gao, Bhanu Priya Ganesh, Zhongcheng Shi, Rajesh Rasik Shah, Robert Fultz, Angela Major, Susan Venable, Monica Lugo, Kathleen Hoch, Xiaowei Chen, Anthony Haag, Timothy C. Wang, James Versalovic

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Microbiome-mediated suppression of carcinogenesis may open new avenues for identification of therapeutic targets and prevention strategies in oncology. Histidine decarboxylase (HDC) deficiency has been shown to promote inflammation-associated colorectal cancer by accumulation of CD11b+Gr-1+ immature myeloid cells, indicating a potential antitumorigenic effect of histamine. Here, we demonstrate that administration of hdc+ Lactobacillus reuteri in the gut resulted in luminal hdc gene expression and histamine production in the intestines of Hdc−/− mice. This histamine-producing probiotic decreased the number and size of colon tumors and colonic uptake of [18F]-fluorodeoxyglucose by positron emission tomography in Hdc−/− mice. Administration of L. reuteri suppressed keratinocyte chemoattractant (KC), Il22, Il6, Tnf, and IL1α gene expression in the colonic mucosa and reduced the amounts of proinflammatory, cancer-associated cytokines, keratinocyte chemoattractant, IL-22, and IL-6, in plasma. Histamine-generating L. reuteri also decreased the relative numbers of splenic CD11b+Gr-1+ immature myeloid cells. Furthermore, an isogenic HDC-deficient L. reuteri mutant that was unable to generate histamine did not suppress carcinogenesis, indicating a significant role of the cometabolite, histamine, in suppression of chronic intestinal inflammation and colorectal tumorigenesis. These findings link luminal conversion of amino acids to biogenic amines by gut microbes and probiotic-mediated suppression of colorectal neoplasia.

Original languageEnglish (US)
Pages (from-to)2323-2336
Number of pages14
JournalAmerican Journal of Pathology
Volume187
Issue number10
DOIs
StatePublished - Oct 2017
Externally publishedYes

Fingerprint

Lactobacillus reuteri
Histamine
Colon
Carcinogenesis
Inflammation
Histidine Decarboxylase
Chemotactic Factors
Probiotics
Myeloid Cells
Keratinocytes
Gene Expression
Neoplasms
Biogenic Amines
Microbiota
Fluorodeoxyglucose F18
Positron-Emission Tomography
Intestines
Colorectal Neoplasms
Interleukin-6
Mucous Membrane

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Gut Microbe–Mediated Suppression of Inflammation-Associated Colon Carcinogenesis by Luminal Histamine Production. / Gao, Chunxu; Ganesh, Bhanu Priya; Shi, Zhongcheng; Shah, Rajesh Rasik; Fultz, Robert; Major, Angela; Venable, Susan; Lugo, Monica; Hoch, Kathleen; Chen, Xiaowei; Haag, Anthony; Wang, Timothy C.; Versalovic, James.

In: American Journal of Pathology, Vol. 187, No. 10, 10.2017, p. 2323-2336.

Research output: Contribution to journalArticle

Gao, C, Ganesh, BP, Shi, Z, Shah, RR, Fultz, R, Major, A, Venable, S, Lugo, M, Hoch, K, Chen, X, Haag, A, Wang, TC & Versalovic, J 2017, 'Gut Microbe–Mediated Suppression of Inflammation-Associated Colon Carcinogenesis by Luminal Histamine Production', American Journal of Pathology, vol. 187, no. 10, pp. 2323-2336. https://doi.org/10.1016/j.ajpath.2017.06.011
Gao, Chunxu ; Ganesh, Bhanu Priya ; Shi, Zhongcheng ; Shah, Rajesh Rasik ; Fultz, Robert ; Major, Angela ; Venable, Susan ; Lugo, Monica ; Hoch, Kathleen ; Chen, Xiaowei ; Haag, Anthony ; Wang, Timothy C. ; Versalovic, James. / Gut Microbe–Mediated Suppression of Inflammation-Associated Colon Carcinogenesis by Luminal Histamine Production. In: American Journal of Pathology. 2017 ; Vol. 187, No. 10. pp. 2323-2336.
@article{8708f14fb82f4715b80f28c1159bb01c,
title = "Gut Microbe–Mediated Suppression of Inflammation-Associated Colon Carcinogenesis by Luminal Histamine Production",
abstract = "Microbiome-mediated suppression of carcinogenesis may open new avenues for identification of therapeutic targets and prevention strategies in oncology. Histidine decarboxylase (HDC) deficiency has been shown to promote inflammation-associated colorectal cancer by accumulation of CD11b+Gr-1+ immature myeloid cells, indicating a potential antitumorigenic effect of histamine. Here, we demonstrate that administration of hdc+ Lactobacillus reuteri in the gut resulted in luminal hdc gene expression and histamine production in the intestines of Hdc−/− mice. This histamine-producing probiotic decreased the number and size of colon tumors and colonic uptake of [18F]-fluorodeoxyglucose by positron emission tomography in Hdc−/− mice. Administration of L. reuteri suppressed keratinocyte chemoattractant (KC), Il22, Il6, Tnf, and IL1α gene expression in the colonic mucosa and reduced the amounts of proinflammatory, cancer-associated cytokines, keratinocyte chemoattractant, IL-22, and IL-6, in plasma. Histamine-generating L. reuteri also decreased the relative numbers of splenic CD11b+Gr-1+ immature myeloid cells. Furthermore, an isogenic HDC-deficient L. reuteri mutant that was unable to generate histamine did not suppress carcinogenesis, indicating a significant role of the cometabolite, histamine, in suppression of chronic intestinal inflammation and colorectal tumorigenesis. These findings link luminal conversion of amino acids to biogenic amines by gut microbes and probiotic-mediated suppression of colorectal neoplasia.",
author = "Chunxu Gao and Ganesh, {Bhanu Priya} and Zhongcheng Shi and Shah, {Rajesh Rasik} and Robert Fultz and Angela Major and Susan Venable and Monica Lugo and Kathleen Hoch and Xiaowei Chen and Anthony Haag and Wang, {Timothy C.} and James Versalovic",
year = "2017",
month = "10",
doi = "10.1016/j.ajpath.2017.06.011",
language = "English (US)",
volume = "187",
pages = "2323--2336",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Gut Microbe–Mediated Suppression of Inflammation-Associated Colon Carcinogenesis by Luminal Histamine Production

AU - Gao, Chunxu

AU - Ganesh, Bhanu Priya

AU - Shi, Zhongcheng

AU - Shah, Rajesh Rasik

AU - Fultz, Robert

AU - Major, Angela

AU - Venable, Susan

AU - Lugo, Monica

AU - Hoch, Kathleen

AU - Chen, Xiaowei

AU - Haag, Anthony

AU - Wang, Timothy C.

AU - Versalovic, James

PY - 2017/10

Y1 - 2017/10

N2 - Microbiome-mediated suppression of carcinogenesis may open new avenues for identification of therapeutic targets and prevention strategies in oncology. Histidine decarboxylase (HDC) deficiency has been shown to promote inflammation-associated colorectal cancer by accumulation of CD11b+Gr-1+ immature myeloid cells, indicating a potential antitumorigenic effect of histamine. Here, we demonstrate that administration of hdc+ Lactobacillus reuteri in the gut resulted in luminal hdc gene expression and histamine production in the intestines of Hdc−/− mice. This histamine-producing probiotic decreased the number and size of colon tumors and colonic uptake of [18F]-fluorodeoxyglucose by positron emission tomography in Hdc−/− mice. Administration of L. reuteri suppressed keratinocyte chemoattractant (KC), Il22, Il6, Tnf, and IL1α gene expression in the colonic mucosa and reduced the amounts of proinflammatory, cancer-associated cytokines, keratinocyte chemoattractant, IL-22, and IL-6, in plasma. Histamine-generating L. reuteri also decreased the relative numbers of splenic CD11b+Gr-1+ immature myeloid cells. Furthermore, an isogenic HDC-deficient L. reuteri mutant that was unable to generate histamine did not suppress carcinogenesis, indicating a significant role of the cometabolite, histamine, in suppression of chronic intestinal inflammation and colorectal tumorigenesis. These findings link luminal conversion of amino acids to biogenic amines by gut microbes and probiotic-mediated suppression of colorectal neoplasia.

AB - Microbiome-mediated suppression of carcinogenesis may open new avenues for identification of therapeutic targets and prevention strategies in oncology. Histidine decarboxylase (HDC) deficiency has been shown to promote inflammation-associated colorectal cancer by accumulation of CD11b+Gr-1+ immature myeloid cells, indicating a potential antitumorigenic effect of histamine. Here, we demonstrate that administration of hdc+ Lactobacillus reuteri in the gut resulted in luminal hdc gene expression and histamine production in the intestines of Hdc−/− mice. This histamine-producing probiotic decreased the number and size of colon tumors and colonic uptake of [18F]-fluorodeoxyglucose by positron emission tomography in Hdc−/− mice. Administration of L. reuteri suppressed keratinocyte chemoattractant (KC), Il22, Il6, Tnf, and IL1α gene expression in the colonic mucosa and reduced the amounts of proinflammatory, cancer-associated cytokines, keratinocyte chemoattractant, IL-22, and IL-6, in plasma. Histamine-generating L. reuteri also decreased the relative numbers of splenic CD11b+Gr-1+ immature myeloid cells. Furthermore, an isogenic HDC-deficient L. reuteri mutant that was unable to generate histamine did not suppress carcinogenesis, indicating a significant role of the cometabolite, histamine, in suppression of chronic intestinal inflammation and colorectal tumorigenesis. These findings link luminal conversion of amino acids to biogenic amines by gut microbes and probiotic-mediated suppression of colorectal neoplasia.

UR - http://www.scopus.com/inward/record.url?scp=85029178141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029178141&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2017.06.011

DO - 10.1016/j.ajpath.2017.06.011

M3 - Article

C2 - 28917668

AN - SCOPUS:85029178141

VL - 187

SP - 2323

EP - 2336

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 10

ER -